SGLT2 Diabetes Drugs Associated with Doubled Risk of Dangerous Levels of Acid in Blood

Medical Drug Safety

A cohort study of 140,352 diabetics showed that sodium-glucose cotransporter 2 (SGLT2 inhibitors) diabetes drugs were associated with approximately twice the risk of diabetic ketoacidosis as were dipeptidyl peptidase-4 (DPP4 inhibitors) diabetes drugs according to a recent letter to the New England Journal of Medicine. SGLT2 inhibitors are a class of prescription medicines that are…

Read More

Ohio Attorney General Sues Drug Companies for Fueling Ohio’s Opioid Addiction Crisis

Medical Drug Safety
Attorney Pamela A. Borgess, the founder of Borgess Law, LLC, is an experienced trial attorney who focuses on civil litigation, including defective medical drugs/devices, defective consumer products, wrongful death and injury, car and truck accidents, business/contract disputes, and nursing home abuse cases. To speak with Attorney Borgess, call Borgess Law at (567) 455-5955 or toll-free at (844) LAW-9144. You can also contact Borgess Law by submitting an online inquiry. Borgess Law never charges for initial consultations.

On May 31, 2017, Ohio Attorney General Mike DeWine filed a lawsuit against five leading prescription opioid manufacturers and their related companies, charging that the drug companies engaged in fraudulent marketing about the risks and benefits of prescription opioids, which misled patients and fueled Ohio’s opioid epidemic. Specifically, the lawsuit (State of Ohio ex rel….

Read More

FDA Issues Drug Safety Communication Regarding Use of General Anesthetic and Sedation Drugs in Young Children

Medical Drug Safety

Today, the FDA issued a drug safety communication that it has approved previously announced label changes regarding the use of general anesthetic and sedation medicines in children younger than 3 years. These changes include: A new Warning stating that exposure to these medicines for lengthy periods of time or over multiple surgeries or procedures may…

Read More

Invokana Litigation Alleging Kidney and Ketoacidosis Injuries Could Become an MDL (Multidistrict Litigation)

Medical Drug Safety

Last week, a motion was filed requesting multidistrict litigation (MDL) for lawsuits of individuals with kidney damage or diabetic ketoacidosis from taking the prescription, Invokana. Invokana (canagliflozin) is an oral prescription used to help lower blood glucose in patients with type 2 diabetes. Multidistrict litigation is a special procedure in which federal civil (noncriminal) cases from around the…

Read More

TAXOTERE PERMANENT HAIR LOSS LAWSUITS COULD BECOME AN MDL (MULTIDISTRICT LITIGATION)

Medical Drug Safety

On July 22, a motion was filed requesting a new multidistrict litigation (MDL) for lawsuits alleging that Sanofi SA’s chemotherapy drug, Taxotere, can cause permanent hair loss, particularly in those being treated for breast cancer. Multidistrict litigation is a special procedure in which federal civil (noncriminal) cases from around the country are transferred to one…

Read More

Popular Heartburn Drugs Linked to Increased Risk of Kidney Damage

Medical Drug Safety

If you are one of the millions of Americans taking heartburn drugs, such as Prevacid, Prilosec, Nexium, Protonix, Aciphex and others, recent studies suggest you could be at an increased risk of kidney disease, kidney disease progression, and end-stage renal disease. Heartburn drugs are called proton pump inhibitors or “PPIs.” They help people who suffer from regular heartburn,…

Read More